Elbit Medical Technologies Ltd. is a holding company, which engages in the field of life sciences and medical equipment. It operates through the Insightec and Gamida Cell segments. The Insightec segment is involved research, development, production, and marketing of therapeutic medical systems based on a technological platform, which combines the use of a focused ultrasound beam and magnetic resonance imaging intended for performing non-invasive treatments on the human body. The Gamida Cell segment offers research and development of medical products based on stem cells derived mainly from umbilical cord blood for the purpose of bone marrow transplantation in patients with non-malignant blood diseases, blood or lymph node cancer, and metabolic genetic diseases. The company was founded on February 23, 1992 and is headquartered in Hod Ha'Sharon, Israel.
Sector:
Miscellaneous
Industry:
Investment Trusts Or Mutual Funds
Employees:
444
Frequently Asked Questions
Market cap, also known as market capitalization, is the total market value of a company. It's calculated by multiplying the current market price by the total number of shares outstanding. Elbit Medical Technologies Ltd market cap is $4.54M.
52 week high is the highest price of a stock in the past 52 weeks, or one year. Elbit Medical Technologies Ltd 52 week high is $0.05 as of November 18, 2026.
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Elbit Medical Technologies Ltd 52 week low is $0.05 as of November 18, 2026.
Elbit Medical Technologies Ltd stock price today is $0.05.
Elbit Medical Technologies Ltd stock price yesterday was $0.06.
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It's calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company's Market Cap by the Net Profit. Elbit Medical Technologies Ltd's P/E ratio is -2.12.
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It's calculated by dividing a company's market capitalization by its book value. Elbit Medical Technologies Ltd P/B ratio is 0.5966.
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It's calculated by averaging the closing stock price over the previous 50 trading days. Elbit Medical Technologies Ltd 50-day moving average is $0.05.